Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS candidate RFK Jr told senators the GLP-1s are ‘miracle drugs’ but shouldn’t ...
Health and Me on MSN19h
Can Weight Loss Drugs Curb Alcoholism? See What Study SaysUntil law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
FOX 7 Austin on MSN22h
More Americans are turning to GLP-1 injections to lose weightMore and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.
PsyPost on MSN21h
Ozempic blindness? Serious vision problems reported in patients taking weight loss medicationsA new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback